Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rheumatoid arthritis, confirmed by a rheumatologist.
- People who are taking anti-inflammatory medications (such as ibuprofen or naproxen) at a steady, unchanged dose for at least 2 weeks before joining the trial.
- People who have been taking their current arthritis disease-modifying medications (whether traditional, targeted, or biological treatments) at a steady, unchanged dose for at least 8 weeks before joining the trial.
Who may not be able to join:
- People who have a known allergy, intolerance, or medical reason preventing them from taking corticosteroid medications (a type of steroid) or receiving injections into a muscle.
- People who currently have an active cancer, or who are pregnant or breastfeeding.
- People who have received steroid treatment — either by mouth/injection into the bloodstream, or directly into a joint — within 4 weeks before joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 416-480-4580
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rheumatoid Arthritis Flare Questionnaire (RA-FQ)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.